[{"id":"1a7ccaaf-9044-4f2f-ae35-54a15ea11dd0","acronym":"","url":"https://clinicaltrials.gov/study/NCT01393730","created_at":"2021-01-18T05:43:26.209Z","updated_at":"2024-07-02T16:37:13.008Z","phase":"Phase 2","brief_title":"Abiraterone Acetate Combined With Dutasteride for Metastatic Castrate Resistant Prostate Cancer","source_id_and_acronym":"NCT01393730","lead_sponsor":"Mary-Ellen Taplin, MD","biomarkers":" AR","pipe":" | ","alterations":" AR mutation • AR T878A • AR amplification","tags":["AR"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e AR mutation • AR T878A • AR amplification"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e abiraterone acetate • prednisone"],"overall_status":"Completed","enrollment":" Enrollment 40","initiation":"Initiation: 09/01/2011","start_date":" 09/01/2011","primary_txt":" Primary completion: 01/01/2016","primary_completion_date":" 01/01/2016","study_txt":" Completion: 03/15/2017","study_completion_date":" 03/15/2017","last_update_posted":"2018-03-15"}]